Kristen Sanfillipo, MD, MPHS

Assistant Professor
Washington University St. Louis School of Medicine

Dr. Kristen Sanfilippo completed her undergraduate work and medical degree at University of Missouri-Columbia before moving to Pittsburgh for her internal medicine residency at University of Pittsburgh Medical Center. She returned to her hometown of St. Louis for fellowship training in Hematology/Oncology at Washington University School of Medicine St. Louis and joined faculty in 2013. She is an Assistant Professor of Medicine in the Division of Hematology at Washington University School of Medicine St. Louis and a Staff Physician in the Division of Hematology/Oncology at John Cochran Veterans Administration Medical Center St. Louis. In addition to fellowship training, she earned a Masters in Population Health Sciences at Washington University in 2012. Since completion of her Master’s degree, Dr. Sanfilippo has focused her research on health outcomes in patients with venous thromboembolism with a focus on cancer-associated thrombosis. Most recently, her research group developed and validated a risk prediction model, IMPEDE VTE, to identify patients with multiple myeloma starting chemotherapy at high-risk of venous thromboembolism. In addition, through a collaboration with a research team at University of Washington School of Medicine, they developed the SAVED score to predict risk of venous thromboembolism in multiple myeloma patients receiving an immunomodulatory agent. Both IMPEDE VTE and the SAVED score are recommended as the risk prediction models of choice by the National Comprehensive Cancer Network (NCCN) clinical guidelines. Her clinical and research interests continue to focus on venous thromboembolism and cancer-associated thrombosis and risks of treatment.

Presentation(s):

• OC 16.6 - Risk Assessment for Bleeding and Thrombosis in Cancer

  Sunday, July 10, 2022
  10:45 AM – 12:00 PM

• OC 16.5 - Available Risk Scores Modestly Predict Hemorrhage in Patients with Cancer-Associated Thrombosis (CAT)

  Sunday, July 10, 2022
  11:45 AM – 12:00 PM

• OC 24.5 - Modest Performance of Available Risk Prediction Models when Used to Predict Hemorrhage in Patients with Chronic Liver Disease

  Sunday, July 10, 2022
  3:45 PM – 4:00 PM

• PB0466 - Physician practice behaviors surrounding dose-reduction of direct oral anticoagulants for the extended phase treatment of venous thromboembolism

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0510 - Multiple Myeloma (MM) is Associated with an Increased Risk of Arterial Thromboembolic Events (ATE)

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• SSC 18.02 - Risk Assessment Models to Predict Cancer-associated Thrombosis (CAT)

  Tuesday, July 12, 2022
  4:35 PM – 4:45 PM

• SSC 18.05 - Q&A

  Tuesday, July 12, 2022
  5:05 PM – 5:15 PM

• SSC 18.10 - Q&A

  Tuesday, July 12, 2022
  5:55 PM – 6:05 PM